Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  selective estrogen receptor degrader ARN-810
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO29642, NCI-2013-00898, 2014-004852-77, ARN-810-001, NCT01823835
A Study of GDC-0810 Versus Fulvestrant in Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy (HydranGea)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GO29689, NCI-2015-02287, NCT02569801
Start Over